The approval was based on positive results from the interim analyses of two Phase III clinical trials, ELEVATE-TN and ASCEND. More: FDA nod for Calquence in CLL Source: News
read moreThe Party’s manifesto puts emphasis on investing in the NHS and increasing expenditure across the health sector, but the BMA says the promises are not enough. More: Labour manifesto needs to ‘go further’ with NHS, says BMA Source: News
read moreThe specialist HIV company has signed an exclusive licensing agreement for an investigational broadly neutralising antibody (bNAb) – N6LS. More: ViiV inks bNAb deal with National Institutes of Health Source: News
read moreThe project aims to move away from traditional printed leaflets, and towards digital systems and immersive content, including some virtual reality content. More: Cognitant wins £30k for VR pilot Source: News
read moreHealth and social care firms invested the second highest amount in cyber security overall in 2018-19. More: Health sector ups cyber security by more than 500% Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals